Nick Abbott

A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues.

Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team.

Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation

BMO Capital Markets Corp. (Broker) is the broker/dealer division of BMO Capital Markets Corp., a full-service North American financial services provider headquartered in New York City. The firm was founded in 1998 and is a subsidiary of BMO Financial Corp., which is owned by Bank of Montreal (NYSE, TSX: BMO) in Canada. BMO Capital Markets offers corporate, institutional and government clients access to a variety of products and services including equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, merchant banking, securitization, treasury and market risk management, debt and equity research and institutional sales and trading.

Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients.

Platypus Technologies LLC specializes in providing services for the design and fabrication of biosensors and chemical sensors. The private company is based in Madison, WI, and has subsidiaries in the United States. The company offers photolithography, wet etching, and metal lift-off services for the fabrication of sensors, biosensors, and microfluidics. The company's Oris™ Pro Cell Migration Assays are ideal for High-Throughput Screening, Drug Discovery, Wound Healing, or Cancer Studies. Platypus Technologies has partnered with GWC to deliver high-quality sensor chips for surface plasmon resonance. The company also offers dicing services for silicon wafers and glass panels. The company was founded in 2000 by Nick Abbott, and the CEO is Marco Bedolla.